Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Getinge ( ($SE:GETI.B) ) has shared an announcement.
Getinge reported a record fourth quarter and full-year 2025 organic sales growth of 4.9%, at the upper end of its guidance, driven by higher demand for ECLS consumables, acute care therapies, transplant care and ventilators, while Surgical Workflows strengthened its leading position in operating tables and entered 2026 with robust order bookings. Despite more than SEK 1 billion in tariff and currency headwinds and a slight decline in adjusted earnings per share and free cash flow versus 2024, the company maintained its full-year adjusted EBITA margin at 14% and achieved significantly higher underlying profitability when excluding these effects, supported by price adjustments, productivity gains and cost control; new product launches such as the Automatiq robotic sterile reprocessing system and regulatory milestones for Rotaflow ECLS consumables and the iCast covered stent further bolstered its competitive position, and management signaled confidence in long-term growth with a proposed higher dividend and an outlook for 3–5% organic sales growth in 2026 despite geopolitical uncertainty.
The most recent analyst rating on ($SE:GETI.B) stock is a Hold with a SEK230.00 price target. To see the full list of analyst forecasts on Getinge stock, see the SE:GETI.B Stock Forecast page.
More about Getinge
Getinge is a Swedish medical technology company that supplies equipment, consumables and digital solutions primarily to hospitals and life science institutions. Its portfolio spans acute care therapies, extracorporeal life support (ECLS), ventilators, transplant care and surgical workflows, including operating tables and sterile reprocessing systems, positioning the group as a key supplier to critical care and operating room environments worldwide.
Average Trading Volume: 471,926
Technical Sentiment Signal: Buy
Current Market Cap: SEK57.72B
Learn more about GETI.B stock on TipRanks’ Stock Analysis page.